GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?

Lancet Diabetes Endocrinol. 2020 Apr;8(4):262-264. doi: 10.1016/S2213-8587(20)30043-7. Epub 2020 Mar 2.

Authors

Michael A Nauck¹, Juris J Meier²

Affiliations

¹ Diabetes Division, Katholisches Klinikum Bochum, St Josef Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany. Electronic address: michael.nauck@rub.de.
² Diabetes Division, Katholisches Klinikum Bochum, St Josef Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany.

PMID: 32135134
DOI: 10.1016/S2213-8587(20)30043-7

No abstract available

Publication types

Comment

MeSH terms

Blood Glucose
Diabetes Mellitus, Type 1*
Double-Blind Method
Exenatide*
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents

Substances

Blood Glucose
Glucagon-Like Peptide-1 Receptor
Hypoglycemic Agents
Exenatide